Breaking news and updates from Nigeria's pharmacy profession.
Health authorities in Ghana have reported an outbreak of acute haemorrhagic conjunctivitis in Sefwi Wiawso Municipality, prompting renewed attention to the highly contagious eye infection and its potential implications for neighbouring countries.
NAFDAC has discontinued the registration of oral ketoconazole tablets in Nigeria following severe risks of fatal liver injury, aligning with global regulatory actions
Minister of Humanitarian Affairs and Poverty Reduction, Dr Bernard Mohammed Doro, has urged pharmacists, particularly younger professionals, to prepare for greater leadership responsibilities while highlighting the frontline role of community pharmacists in Nigeria’s healthcare system.
Nigeria is advancing plans to produce family planning commodities locally, as the Federal Government links domestic manufacturing to reduced import dependence, job creation and stronger human capital development.
The PSN-YPG Kaduna State chapter has commended Dialogue Pharmacy for supporting pharmacist employment, internship opportunities, professional development and workplace recognition during a courtesy visit to its leadership
NAFDAC has alerted Nigerians to a suspected counterfeit Pulmicort (budesonide) product marketed as “Ulmicort 0.5 mg/ml Inhalation Suspension”, detected in Eastern Nigeria and currently under investigation.
NAFDAC has alerted Nigerians to two suspected counterfeit products mimicking AstraZeneca’s Forxiga (dapagliflozin), detected in Eastern Nigeria, and directed surveillance and mop-up operations to remove them from circulation.
The Federal Government has directed the immediate implementation of new measures to protect health workers across Nigeria, following a ministerial committee's findings that violence, intimidation and harassment against healthcare personnel are recurring challenges in federal tertiary health institutions.
Nigeria has destroyed 207 containers of illicit drugs in a major enforcement operation coordinated by the Office of the National Security Adviser, with regulatory and security agencies describing the exercise as a significant step towards protecting public health and strengthening the country's pharmaceutical supply chain.
NAFDAC has warned Nigerians against the marketing and sale of an unregistered product, Menofix Capsules, following complaints and concerns about potential liver-related adverse effects. The agency says the product has not been evaluated for safety, quality, or efficacy.
NAFDAC has joined an international research consortium awarded a £3.7 million UK grant to develop innovative technologies for detecting substandard and falsified vaccines, a move expected to strengthen vaccine quality surveillance and regulatory decision-making in Nigeria.
Pharma West Africa will return to Lagos from 13–15 April 2027, bringing together pharmaceutical manufacturers, regulators, distributors and healthcare professionals as West Africa's pharmaceutical market continues to attract growing international interest.
